Secondary prophylaxis with warfarin for venous thromboembolism

[1] Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis. [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (03) : 165 - 169

[2] BARRITT DW, 1960, LANCET, V1, P1309

[3] ACENOCOUMAROL AND HEPARIN COMPARED WITH ACENOCOUMAROL ALONE IN THE INITIAL TREATMENT OF PROXIMAL-VEIN THROMBOSIS [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (21) : 1485 - 1489

[4] HULL R, 1979, NEW ENGL J MED, V301, P855, DOI 10.1056/NEJM197910183011602

[5] DIFFERENT INTENSITIES OF ORAL ANTICOAGULANT-THERAPY IN THE TREATMENT OF PROXIMAL-VEIN THROMBOSIS [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1982, 307 (27) : 1676 - 1681

[6] Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (07) : 631 - 639

[7] LAGERSTEDT CI, 1985, LANCET, V2, P515

[8] Prins MH, 1999, THROMB HAEMOSTASIS, V82, P892

[9] Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (15) : 1425 - 1434

[10] The incidence of recurrent venous thromboembolism after treatment with vitamin K antagonists in relation to time since first event -: A meta-analysis [J]. ARCHIVES OF INTERNAL MEDICINE, 2003, 163 (11) : 1285 - 1293

[1] Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis. [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (03) : 165 - 169

[2] BARRITT DW, 1960, LANCET, V1, P1309

[3] ACENOCOUMAROL AND HEPARIN COMPARED WITH ACENOCOUMAROL ALONE IN THE INITIAL TREATMENT OF PROXIMAL-VEIN THROMBOSIS [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (21) : 1485 - 1489

[4] HULL R, 1979, NEW ENGL J MED, V301, P855, DOI 10.1056/NEJM197910183011602

[5] DIFFERENT INTENSITIES OF ORAL ANTICOAGULANT-THERAPY IN THE TREATMENT OF PROXIMAL-VEIN THROMBOSIS [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1982, 307 (27) : 1676 - 1681

[6] Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (07) : 631 - 639

[7] LAGERSTEDT CI, 1985, LANCET, V2, P515

[8] Prins MH, 1999, THROMB HAEMOSTASIS, V82, P892

[9] Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (15) : 1425 - 1434

[10] The incidence of recurrent venous thromboembolism after treatment with vitamin K antagonists in relation to time since first event -: A meta-analysis [J]. ARCHIVES OF INTERNAL MEDICINE, 2003, 163 (11) : 1285 - 1293